NCT06194955View on ClinicalTrials.gov

The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 4, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Incretin Effect
Interventions
DRUG

GIP(1-42)

Infusion

DRUG

GLP-1

Infusion

DRUG

GLP-2

Infusion

OTHER

Placebo

Saline

Trial Locations (1)

2900

RECRUITING

Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup

All Listed Sponsors
collaborator

Gentofte Hospital, Denmark

UNKNOWN

lead

University of Copenhagen

OTHER